Exousia Bio, Inc. (LMMY)
About Exousia Bio, Inc.
L A M Y
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $3.8K
- Net income
- $51.4K
- Total assets
- $0
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Exousia Bio, Inc. (LMMY) Stock Price
- Profitable — net income of $51.4K in FY2025.
- Trading 45% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Exousia Bio, Inc..
Write a review
News about Exousia Bio, Inc.
News & sentiment via Polygon.io
Exousia Bio, Inc.: frequently asked questions
Is Exousia Bio, Inc. an American company?
Exousia Bio, Inc. is a US-based company headquartered in St. Petersburg, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Exousia Bio, Inc. headquartered?
Exousia Bio, Inc. is headquartered in St. Petersburg, Florida, United States.
Is Exousia Bio, Inc. publicly traded?
Yes — Exousia Bio, Inc. is a publicly traded company. Its stock trades under the ticker symbol LMMY on the OTC.
